SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-010350
Filing Date
2013-08-09
Accepted
2013-08-09 09:06:42
Documents
12
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ipxl20130630_10q.htm 10-Q 1793988
2 EXHIBIT 10.4 ex10-4.htm EX-10 77435
3 EXHIBIT 31.1 ex31-1.htm EX-31 13428
4 EXHIBIT 31.2 ex31-2.htm EX-31 13929
5 EXHIBIT 32.1 ex32-1.htm EX-32 6541
6 EXHIBIT 32.2 ex32-2.htm EX-32 6807
  Complete submission text file 0001437749-13-010350.txt   15386268

Data Files

Seq Description Document Type Size
7 EXHIBIT 101.INS ipxl-20130630.xml EX-101.INS 1985872
8 EXHIBIT 101.SCH ipxl-20130630.xsd EX-101.SCH 76915
9 EXHIBIT 101.CAL ipxl-20130630_cal.xml EX-101.CAL 47568
10 EXHIBIT 101.DEF ipxl-20130630_def.xml EX-101.DEF 282795
11 EXHIBIT 101.LAB ipxl-20130630_lab.xml EX-101.LAB 479366
12 EXHIBIT 101.PRE ipxl-20130630_pre.xml EX-101.PRE 286519
Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
IMPAX LABORATORIES INC (Filer) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34263 | Film No.: 131024647
SIC: 2834 Pharmaceutical Preparations